SG

Swati Gupta

AbbVie Biotherapeutics, University of Nebraska–Lincoln, IIT@MIT, Rashtrasant Tukadoji Maharaj Nagpur University

ORCID iD 0000-0002-3727-6647
Follow

About

Dr. Swati Gupta is the Executive Director at AbbVie, in Irvine, California. She is with the company for last 13 years where she leads the Immunology group in Nonclinical and Translational Sciences function. She is serving as an internal consultant and resident expert to provide guidance and advice for risk assessment on modulation of the immune system for therapeutics and devices with a focus on immunogenicity. This group own the responsibilities and provides oversight to ensure compliance with immunology procedures, strategies and processes following expectations from the FDA, EMA and other regulatory agencies. Prior to AbbVie, Dr. Gupta led different positions in leading groups on Clinical Immunogenicity, Bioassay/CMC, Bioanalytical in various pharmaceutical companies like BMS, and Eli Lilly. Dr. Gupta received her Ph.D. degree in Biochemistry/Chemistry from University of Nebraska, Lincoln and did her post-doctoral training at the University of California School of Medicine, Irvine in the Department of Microbiology and Molecular Genetics. Dr. Gupta has several publications in peer-reviewed journals and has in-depth experience in bioanalytical assays in characterizing bio-therapeutics to support mechanism of action, pharmacokinetics, immunogenicity and product release. She is currently actively participating in IQ consortium for TALG- Gene therapy, Cell-Therapy- oligos. She is also participating in AAPS Immunogenicity Risk Assessment community and is contributing to in vitro method harmonization.

Employment

  • AbbVie Biotherapeutics

Education

  • University of Nebraska–Lincoln Ph.D.
  • IIT@MIT M.Tech.
  • Rashtrasant Tukadoji Maharaj Nagpur University M.Sc.
  • Rashtrasant Tukadoji Maharaj Nagpur University B.Sc.

Projects & Funding

Projects & funding information is unavailable.

Publications (24)